[
  {
    "ts": "2025-08-30T14:00:14+00:00",
    "headline": "With 81% ownership of the shares, Amgen Inc. (NASDAQ:AMGN) is heavily dominated by institutional owners",
    "summary": "Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...",
    "url": "https://finance.yahoo.com/news/81-ownership-shares-amgen-inc-140014185.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "7b58f4e8-5aac-339d-b99e-4c889a641052",
      "content": {
        "id": "7b58f4e8-5aac-339d-b99e-4c889a641052",
        "contentType": "STORY",
        "title": "With 81% ownership of the shares, Amgen Inc. (NASDAQ:AMGN) is heavily dominated by institutional owners",
        "description": "",
        "summary": "Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...",
        "pubDate": "2025-08-30T14:00:14Z",
        "displayTime": "2025-08-30T14:00:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACuIXYrNeojUXbAJFhnPIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7CQJIEa.2c0sQ0XIU66pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/81-ownership-shares-amgen-inc-140014185.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/81-ownership-shares-amgen-inc-140014185.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-30T10:15:30+00:00",
    "headline": "Does Imdelltra Royalty Deal Reinforce Royalty Pharma’s Long-Term Asset Strategy (RPRX)?",
    "summary": "Royalty Pharma announced it has acquired a royalty interest in Amgen’s Imdelltra from BeOne Medicines for US$885 million upfront, with an option to purchase up to an additional US$65 million in royalties over the next 12 months. This transaction gives Royalty Pharma a share in the worldwide sales of Imdelltra, a newly approved therapy for small cell lung cancer with analyst projections of more than US$2.8 billion in annual sales by 2035. We'll examine how Royalty Pharma’s investment in...",
    "url": "https://finance.yahoo.com/news/does-imdelltra-royalty-deal-reinforce-101530588.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "cf10652b-21fa-3534-8ee9-5d2c32d2c04c",
      "content": {
        "id": "cf10652b-21fa-3534-8ee9-5d2c32d2c04c",
        "contentType": "STORY",
        "title": "Does Imdelltra Royalty Deal Reinforce Royalty Pharma’s Long-Term Asset Strategy (RPRX)?",
        "description": "",
        "summary": "Royalty Pharma announced it has acquired a royalty interest in Amgen’s Imdelltra from BeOne Medicines for US$885 million upfront, with an option to purchase up to an additional US$65 million in royalties over the next 12 months. This transaction gives Royalty Pharma a share in the worldwide sales of Imdelltra, a newly approved therapy for small cell lung cancer with analyst projections of more than US$2.8 billion in annual sales by 2035. We'll examine how Royalty Pharma’s investment in...",
        "pubDate": "2025-08-30T10:15:30Z",
        "displayTime": "2025-08-30T10:15:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pVOKMAerbRsXv56pHka6Lw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EmyGBi4taxQExvvwka_9KQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/does-imdelltra-royalty-deal-reinforce-101530588.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/does-imdelltra-royalty-deal-reinforce-101530588.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RPRX"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]